TMCnet News
Research and Markets: Global Malignant Glioma Clinical Trials Review 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/grlsf3/malignant_glioma) has announced the addition of the "Malignant Glioma Global Clinical Trials Review, H1, 2014" report to their offering. "Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of th sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Glioma. Scope
Top Companies/Organisations Participating in Malignant Glioma Therapeutics Clinical Trials
For more information visit http://www.researchandmarkets.com/research/grlsf3/malignant_glioma
|